tiprankstipranks
Blurbs

Analysts Offer Insights on Healthcare Companies: Alaunos Therapeutics (TCRT), Anixa Biosciences (ANIX) and Autolus Therapeutics (AUTL)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Alaunos Therapeutics (TCRTResearch Report), Anixa Biosciences (ANIXResearch Report) and Autolus Therapeutics (AUTLResearch Report).

Alaunos Therapeutics (TCRT)

In a report released today, Swayampakula Ramakanth from H.C. Wainwright reiterated a Hold rating on Alaunos Therapeutics. The company’s shares closed last Wednesday at $0.66, close to its 52-week low of $0.61.

According to TipRanks.com, Ramakanth is a 4-star analyst with an average return of 10.0% and a 42.3% success rate. Ramakanth covers the Healthcare sector, focusing on stocks such as Corvus Pharmaceuticals, Janux Therapeutics Inc, and Corcept Therapeutics.

Alaunos Therapeutics has an analyst consensus of Hold.

See today’s best-performing stocks on TipRanks >>

Anixa Biosciences (ANIX)

H.C. Wainwright analyst Yi Chen reiterated a Buy rating on Anixa Biosciences today and set a price target of $11.00. The company’s shares closed last Wednesday at $2.82, close to its 52-week low of $2.30.

According to TipRanks.com, Chen is a 3-star analyst with an average return of 4.3% and a 36.9% success rate. Chen covers the Healthcare sector, focusing on stocks such as Ortho Clinical Diagnostics Holdings, HTG Molecular Diagnostics, and EyePoint Pharmaceuticals.

Currently, the analyst consensus on Anixa Biosciences is a Moderate Buy with an average price target of $11.00.

Autolus Therapeutics (AUTL)

In a report released today, Robert Burns from H.C. Wainwright reiterated a Buy rating on Autolus Therapeutics, with a price target of $11.00. The company’s shares closed last Wednesday at $4.23.

According to TipRanks.com, Burns is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of -22.1% and a 21.2% success rate. Burns covers the Healthcare sector, focusing on stocks such as Turning Point Therapeutics, Black Diamond Therapeutics, and Springworks Therapeutics.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Autolus Therapeutics with a $14.00 average price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on TCRT:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles